Latest Insider Transactions at Alleghany Corp (Y)
This section provides a real-time view of insider transactions for Alleghany Corp (Y). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALLEGHANY CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALLEGHANY CORP 's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 19
2022
|
Joseph Patrick Brandon President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,939
-100.0%
|
-
|
Oct 19
2022
|
Lauren M Tyler Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,218
-100.0%
|
-
|
Oct 19
2022
|
Phillip M Martineau Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,772
-100.0%
|
-
|
Oct 19
2022
|
John F Shannon SVP, Chief Investment Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
371
-100.0%
|
-
|
Oct 19
2022
|
Ian H Chippendale Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,765
-100.0%
|
-
|
Oct 19
2022
|
Karen Brenner Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,641
-100.0%
|
-
|
Oct 19
2022
|
Raymond Wong Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,200
-100.0%
|
-
|
Oct 19
2022
|
Raymond Wong Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,119
-100.0%
|
-
|
Oct 19
2022
|
Christopher Kent Dalrymple SVP, General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,810
-100.0%
|
-
|
Oct 19
2022
|
Jefferson Kirby Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
239,330
-100.0%
|
-
|
Oct 19
2022
|
Jefferson Kirby Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
93,760
-100.0%
|
-
|
Oct 19
2022
|
Kerry J Jacobs EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,459
-100.0%
|
-
|
Oct 19
2022
|
John G Foos Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,936
-100.0%
|
-
|
Oct 19
2022
|
Chris H Cheesman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
134
-100.0%
|
-
|
Mar 22
2022
|
John G Foos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
223
+5.36%
|
$72,698
$326.74 P/Share
|
Mar 07
2022
|
Kerry J Jacobs EVP, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50
+3.31%
|
$32,200
$644.75 P/Share
|
Mar 04
2022
|
Joseph Patrick Brandon President and CEO |
BUY
Open market or private purchase
|
Direct |
585
+0.37%
|
$380,835
$651.86 P/Share
|
Mar 04
2022
|
Kerry J Jacobs EVP, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50
+3.43%
|
$32,900
$658.91 P/Share
|
Feb 28
2022
|
Joseph Patrick Brandon President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,482
-14.88%
|
$3,629,084
$662.26 P/Share
|
Feb 28
2022
|
Joseph Patrick Brandon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,482
+12.95%
|
$3,629,084
$662.26 P/Share
|
Feb 28
2022
|
Kerry J Jacobs EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
142
-9.46%
|
$94,004
$662.26 P/Share
|
Feb 28
2022
|
Kerry J Jacobs EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
255
+14.52%
|
$168,810
$662.26 P/Share
|
Feb 28
2022
|
Christopher Kent Dalrymple SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
293
-7.14%
|
$195,138
$666.15 P/Share
|
Feb 28
2022
|
Christopher Kent Dalrymple SVP, General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,417
-25.67%
|
$938,054
$662.26 P/Share
|
Feb 28
2022
|
Christopher Kent Dalrymple SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,555
+21.98%
|
$1,029,410
$662.26 P/Share
|
Feb 28
2022
|
John F Shannon SVP, Chief Investment Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
63
-14.52%
|
$41,706
$662.26 P/Share
|
Feb 28
2022
|
John F Shannon SVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
174
+28.62%
|
$115,188
$662.26 P/Share
|
Feb 21
2022
|
John F Shannon SVP, Chief Investment Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50
-16.13%
|
$34,200
$684.26 P/Share
|
Feb 21
2022
|
John F Shannon SVP, Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
130
+29.55%
|
-
|
Jan 26
2022
|
Kerry J Jacobs EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
90
-6.74%
|
$58,320
$648.89 P/Share
|
Jan 26
2022
|
Kerry J Jacobs EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
199
+12.96%
|
-
|
Jan 26
2022
|
Christopher Kent Dalrymple SVP, General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
611
-13.35%
|
$395,928
$648.89 P/Share
|
Jan 26
2022
|
Christopher Kent Dalrymple SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
611
+11.78%
|
-
|
Dec 08
2021
|
Ian H Chippendale Director |
SELL
Open market or private sale
|
Direct |
270
-8.89%
|
$181,710
$673.4 P/Share
|
Dec 07
2021
|
Ian H Chippendale Director |
SELL
Payment of exercise price or tax liability
|
Direct |
253
-7.69%
|
$171,028
$676.11 P/Share
|
Dec 07
2021
|
Ian H Chippendale Director |
BUY
Exercise of conversion of derivative security
|
Direct |
523
+13.72%
|
$170,498
$326.74 P/Share
|
Dec 02
2021
|
Joseph Patrick Brandon President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+1.57%
|
$1,645,000
$658.53 P/Share
|
Dec 01
2021
|
Joseph Patrick Brandon President and CEO |
BUY
Open market or private purchase
|
Direct |
3,500
+0.94%
|
$2,292,500
$655.45 P/Share
|
Nov 30
2021
|
Joseph Patrick Brandon President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+1.23%
|
$1,630,000
$652.4 P/Share
|
Nov 23
2021
|
Raymond Wong Director |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-3.0%
|
$170,829
$703.18 P/Share
|
Nov 23
2021
|
Raymond Wong Director |
BUY
Exercise of conversion of derivative security
|
Direct |
523
+6.07%
|
$170,498
$326.74 P/Share
|
Nov 23
2021
|
Raymond Wong Director |
SELL
Bona fide gift
|
Direct |
503
-6.23%
|
-
|
Sep 21
2021
|
Chris H Cheesman Director |
BUY
Grant, award, or other acquisition
|
Direct |
134
+50.0%
|
-
|
May 25
2021
|
Christopher Kent Dalrymple SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
2,000
-11.92%
|
$1,422,000
$711.03 P/Share
|
Apr 26
2021
|
Ian H Chippendale Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+7.65%
|
-
|
Apr 26
2021
|
John G Foos Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+5.81%
|
-
|
Apr 26
2021
|
Phillip M Martineau Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+5.72%
|
-
|
Apr 26
2021
|
Lauren M Tyler Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+9.36%
|
-
|
Apr 26
2021
|
Karen Brenner Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+4.7%
|
-
|
Apr 26
2021
|
Raymond Wong Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+2.76%
|
-
|